• About
    • Who We Are
    • Approach
    • Mission and Vision
    • Our Leadership
  • Science
    • Our Platform
    • R&D Engine
    • Publications
  • Pipeline
    • Overview
    • PEEL-224
    • EP53
    • Melittin
    • NTPs
  • Careers
    • Our Culture
    • Open Positions
  • News
    • Press Releases
    • In the News
  • Contact
    • Get in Touch
    • Linked In
    • Twitter
    • Instagram
  • Menu Menu
  • Home
  • About
    • Who We Are
    • Approach
    • Mission and Vision
    • Our Leadership
  • Science
    • Our Platform
    • R&D Engine
    • Publications
  • Pipeline
    • Overview
    • PEEL-224
    • EP53
    • Melittin
    • NTPs
  • Careers
    • Our Culture
    • Open Positions
  • News
    • Press Releases
    • In the News
  • Contact
    • Get in Touch
    • Linked In
    • Twitter
    • Instagram

PEEL Therapeutics Preps IND for Prodrug Targeting Chemoresistant Tumors

August 25, 2020/in In The News/by Emily Hennes

)%20application%20with%20the%20FDA.

https://peeltx.com/wp-content/uploads/biospace_logo.png 35 130 Emily Hennes /wp-content/uploads/peel_logo.svg Emily Hennes2020-08-25 08:00:252022-06-23 16:48:25PEEL Therapeutics Preps IND for Prodrug Targeting Chemoresistant Tumors
  • Home
  • About
    • Who We Are
    • Approach
    • Mission and Vision
    • Our Leadership
  • Science
    • Our Platform
    • R&D Engine
    • Publications
  • Pipeline
    • Overview
    • PEEL-224
    • EP53
    • Melittin
    • NTPs
  • Careers
    • Our Culture
    • Open Positions
  • News
    • Press Releases
    • In the News
  • Contact
    • Get in Touch
    • Linked In
    • Twitter
    • Instagram
  • Home
  • About
    • Who We Are
    • Approach
    • Mission and Vision
    • Our Leadership
  • Science
    • Our Platform
    • R&D Engine
    • Publications
  • Pipeline
    • Overview
    • PEEL-224
    • EP53
    • Melittin
    • NTPs
  • Careers
    • Our Culture
    • Open Positions
  • News
    • Press Releases
    • In the News
  • Contact
    • Get in Touch
    • Linked In
    • Twitter
    • Instagram
  • Home
  • About
    • Who We Are
    • Approach
    • Mission and Vision
    • Our Leadership
  • Science
    • Our Platform
    • R&D Engine
    • Publications
  • Pipeline
    • Overview
    • PEEL-224
    • EP53
    • Melittin
    • NTPs
  • Careers
    • Our Culture
    • Open Positions
  • News
    • Press Releases
    • In the News
  • Contact
    • Get in Touch
    • Linked In
    • Twitter
    • Instagram
  • Home
  • About
    • Who We Are
    • Approach
    • Mission and Vision
    • Our Leadership
  • Science
    • Our Platform
    • R&D Engine
    • Publications
  • Pipeline
    • Overview
    • PEEL-224
    • EP53
    • Melittin
    • NTPs
  • Careers
    • Our Culture
    • Open Positions
  • News
    • Press Releases
    • In the News
  • Contact
    • Get in Touch
    • Linked In
    • Twitter
    • Instagram

© 2023 Peel Therapeutics | All rights reserved |

Privacy Policy | Site Terms
Podcast | OsteoBitesNeutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute... Scroll to top